Solstice Pharmaceuticals

Developer of ultrasound contrast agents for the diagnosis of multiple diseases

placeEnschede, Overijssel, Netherlands calendar_todayFounded 2020 groups5 employees language solsticepharma.com

Innovation

2 patent families — focus: Human necessities; filing pace slowing. Cited 13 times.

YearFilings
20232

Social engagement

Social engagement: 758 social following, 3 posts in the last 12 months — top 10% of its industry.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

10 May 2026
Event
190th Meeting of the Acoustical Society of America
22 Jan 2026
Event
31st European Symposium on Ultrasound Contrast Imaging
Coming soon